Healthcare providers are exploring ways to reduce patient travel through a growing trend of expanding sites of administration ...

A new survey by Johnson & Johnson revealed that oncologists are overwhelmed by the rapid pace of innovation in cancer care, ...

Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the ...

Kaminski and his colleagues were pioneers in applying high-throughput, genome-scale transcript profiling to advanced lung ...

Patients who were positive for cytomegalovirus had more immune cells circulating in their blood before they started ...

Specialty drugs are increasingly entering general medicine. Experts at Asembia’s AXS Summit say the trend will put a premium ...

In a conversation with Managed Healthcare Executive, 10XBeta CEO Marcel Botha warned that proposed Medicaid cuts, combined ...

Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the ...

Every health plan is unique and will ultimately weigh the risks and benefits of a given use case differently. We developed a ...

Previously used to treat HIV and Hepatitis B, nucleoside reverse transcriptase inhibitors (NRTIs) reduced the risk of ...

The multiple myeloma armamentarium is large and getting larger. That makes treatment choices complex and the cost of ...

The first CAR-T cell therapy was developed and approved by the FDA in 2017 to treat relapsed or refractory B-cell precursor ...